関連ニュース

mAbxience and Sandoz have entered into a collaboration agreement combining mAbxience's development and manufacturing expertise with Sandoz's global commercial capabilities for a proposed emicizumab bi

Sandoz Group AG (SDZNY) Q2 2026 Earnings Call Transcript